Srikar Biotech Private Limited, a active private limited company, was established on 26 May 2008 in Hyderabad, Telangana, India. Engaging in crop protection within the trade sector, it holds CIN: U85100TG2008PTC059337. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹39.75 Cr.
It upholds a compliant status. Employing 61 professional, Its leadership includes Usha Rani Papineni (Director), Srinivasa Rao Linga (Director), Karunasree Samudrala (Additional Director). Past directors included Sanjeev Jakkanisanjeev. It holds ₹412.84 Cr open charges and ₹52.50 Cr settled loans. Its latest AGM occurred on 16 December 2024, with the balance sheet filed on 31 March 2024. It is based at Shed-1, Plot No.A11 & A12/1 Ida Nacharam, Medchal, Hyderabad, Telangana, 500076.
U85100TG2008PTC059337
059337
26 May 2008
₹50.00 Cr
₹39.75 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Srikar Biotech Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Usha Rani Papineni | Director | 26 May 2008 | Current |
| Srinivasa Rao Linga | Director | 26 May 2008 | Current |
| Karunasree Samudrala | Additional Director | 21 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Cfo | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Srikar Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 6.38% increase. The company also saw a substantial improvement in profitability, with a 18.85% increase in profit. The company's net worth Soared by an impressive increase of 27.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Srikar Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,128,395,824.00
₹524,998,235.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2025 | Hdfc Bank Limited | ₹73.70 Cr | Open |
| 20 Jun 2025 | Hdfc Bank Limited | ₹86.49 Cr | Open |
| 20 Jun 2025 | The Hongkong And Shanghai Banking Corporation Limited | ₹57.35 Cr | Open |
| 05 Mar 2025 | Hdfc Bank Limited | ₹53.28 Cr | Open |
| 27 Sep 2024 | Others | ₹30.00 Cr | Open |
Explore comprehensive loan charge details -
Srikar Biotech has a workforce of 61 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Srikar Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srikar Biotech's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Hdfc Bank Limited of Rs. 73.70 Cr registered on 20 Jun 2025 with Charge ID 101136949 was modified on 08 Sep 2025. was completed.
Progress on A charge with Hdfc Bank Limited of Rs. 34.46 Cr registered on 30 Jul 2021 with Charge ID 100467951 was modified on 08 Sep 2025. was documented.
The activity Karunasree Samudrala was appointed as a Additional Director was appointed as a Additional Director on 21 Jul 2025 & has been associated with this company since 4 months 15 days . was completed.
Progress on A charge registered on 18 Sep 2021 via Charge ID 100496741 with Hdfc Bank Limited was fully satisfied on 11 Jul 2025. was documented.
A charge registered on 08 Sep 2021 via Charge ID 100483474 with Hdfc Bank Limited was fully satisfied on 11 Jul 2025. was recorded as a recent event.
The activity A charge registered on 04 Sep 2021 via Charge ID 100480715 with Hdfc Bank Limited was fully satisfied on 11 Jul 2025. was completed.
The CIN of Srikar Biotech Private Limited is U85100TG2008PTC059337.
Srikar Biotech Private Limited is headquartered at Shed-1, Plot No.A11 & A12/1 Ida Nacharam, Medchal, Hyderabad, Telangana, 500076.
Srikar Biotech Private Limited was incorporated on 26 May 2008.
The current directors of Srikar Biotech Private Limited are
The primary industry of Srikar Biotech Private Limited is Trade.
Srikar Biotech Private Limited is unlisted.
The authorized capital of Srikar Biotech Private Limited is ₹50.00 Cr, and the paid-up capital is ₹39.75 Cr.
The compliance status of Srikar Biotech Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX